指南与共识心脑血管急症重症综合管理与镇静镇痛

急诊室评估与建议及老年女性新发主要神经认知障碍的风险筛查:基于观察性人群队列研究的结果

Emergency Room Evaluation and Recommendations and Risk Screening of Incident Major Neurocognitive Disorders in Older Females: Results of an Observational Population-Based Cohort Study.
指南 / 共识 · Front Aging Neurosci · 2022-07-22
一句话结论在EPIDOS队列中,ER2高风险水平与7年内新发主要神经认知障碍(HR≥1.40,P≤0.018)及阿尔茨海默病(HR≥1.80,P≤0.003)相关,提示ER2可用于老年人群MNCD风险筛查。

本研究基于EPIDOS观察性人群队列,在法国图卢兹招募709名社区居住老年人,基线时评定ER2低、中、高风险水平,随访7年后诊断新发主要神经认知障碍(MNCD)及其类型(阿尔茨海默病 vs 非阿尔茨海默病)。MNCD总体发生率为29.1%。低ER2风险水平与新发MNCD低发生率相关(HR=0.71,P=0.018)及AD低发生率相关(HR=0.56,P=0.003);高风险水平单独及与中风险合并均与新发MNCD高发生率相关(HR≥1.40,P≤0.018)及AD高发生率相关(HR≥1.80,P≤0.003)。与非AD无关联。结论提示ER2风险水平与EPIDOS参与者新发MNCD正相关,ER2可能用于老年人群MNCD风险筛查。

要点

  • 在709名社区居住老年人中,7年随访MNCD总体发生率为29.1%。
  • 低ER2风险水平与新发MNCD低发生率相关(HR=0.71,P=0.018),与AD低发生率相关(HR=0.56,P=0.003)。
  • 高ER2风险水平单独及与中风险合并均与新发MNCD高发生率相关(HR≥1.40,P≤0.018)。
  • 高ER2风险水平单独及与中风险合并均与新发AD高发生率相关(HR≥1.80,P≤0.003)。
  • ER2风险水平与新发非AD无关联,提示ER2可能用于老年人群MNCD风险筛查。

适用人群与场景

  • EPIDOS研究的709名社区居住老年人,招募于法国图卢兹。

诊断标准与关键阈值

  • ER2风险水平分为低、中、高三个等级,于基线时评定。
  • 新发MNCD及其类型(阿尔茨海默病 vs 非阿尔茨海默病)于7年随访后诊断。

研究设计与关键结果

  • 研究类型:观察性人群队列研究(EPIDOS研究),样本量709名,招募于法国图卢兹,随访7年。
  • MNCD总体发生率为29.1%。
  • 低ER2风险水平与新发MNCD低发生率相关(HR=0.71,P=0.018),与新发AD低发生率相关(HR=0.56,P=0.003)。
  • 高ER2风险水平单独及与中风险合并均与新发MNCD高发生率相关(HR≥1.40,P≤0.018),与新发AD高发生率相关(HR≥1.80,P≤0.003)。
  • ER2风险水平与新发非AD无关联。

证据类型、等级与局限

  • 证据类型:观察性人群队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,ER2风险水平与EPIDOS参与者新发MNCD正相关,提示ER2可能用于老年人群MNCD风险筛查。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: "Emergency Room Evaluation and Recommendations" (ER2) risk levels (i.e., low, moderate and high) may be used to screen for major neurocognitive disorders (MNCD) in older emergency department users, as a high ER2 risk level is associated with MNCD diagnosis. This study aims to examine the association of ER2 risk levels with incident MNCD in community-dwelling older adults.

METHODS: A total of 709 participants of the EPIDémiologie de l'OStéoporose (EPIDOS) study-an observational population-based cohort study-were recruited in Toulouse (France). ER2 low, moderate and high risk levels were determined at baseline. Incident MNCD and their type (i.e., Alzheimer's disease (AD) vs. non-AD) were diagnosed after a 7-year follow-up period.

RESULTS: The overall incidence of MNCD was 29.1%. A low ER2 risk level was associated with low incidence of MNCD [Hazard ratio (HR) = 0.71 with P = 0.018] and AD (HR = 0.56 with P = 0.003), whereas a high risk level, both individually and when combined with a moderate risk level, was associated with high incidence of MNCD (HR ≥ 1.40 with P ≤0.018) and AD (HR ≥ 1.80 with P ≤ 0.003). No association was found with incident non-AD.

CONCLUSION: ER2 risk levels were positively associated with incident MNCD in EPIDOS participants, suggesting that ER2 may be used for risk screening of MNCD in the older population.

来源:Front Aging Neurosci,查看原文。版权归原作者所有。

参考来源

  1. Beauchet O, Matskiv J, Launay CP, et al. Emergency Room Evaluation and Recommendations and Risk Screening of Incident Major Neurocognitive Disorders in Older Females: Results of an Observational Population-Based Cohort Study. Front Aging Neurosci. 2022. PMID: 35936765. doi:10.3389/fnagi.2022.912477

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。